Table of ContentsView AllTable of ContentsTreatmentWhat to ExpectGetting Help With CostsFrequently Asked QuestionsNext in Hepatitis C GuideHow Hepatitis C Is Transmitted (and How It Isn’t)
Table of ContentsView All
View All
Table of Contents
Treatment
What to Expect
Getting Help With Costs
Frequently Asked Questions
Next in Hepatitis C Guide
Prior to the introduction of a new class of drugs calleddirect-acting antivirals (DAAs)in 2013, hepatitis C was very difficult to treat. Today, DAAs offer cure rates of more than 90%.
Deepak Sethi / Getty Images
So successful are these new drugs that both the American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA) have recommended immediate treatment of all people diagnosed withacute or chronichepatitis C (with the exception of those with a short life expectancy owing to liver disease).
This article takes a look at the high cost of hepatitis C treatment, what to expect when undergoing treatment, and ways to reduce the out-of-pocket expenses associated with HCV therapy.
How Hepatitis C Is Diagnosed
Hepatitis C Treatment
Hepatitis C was only officially identified as a uniquehepatitis virusin 1989.By 1991, the Food and Drug Administration (FDA) approved the first treatment for HCV—ribavirin and interferon-alfa. Interferon-alfa had a cure rate of only 6%.
While newer and more effective therapies were introduced over the next 20 years, it was only with the 2013 introduction of the first DAA, Sovaldi (sofosbuvir), that the game officially changed.A virus once considered incurable was now curable in over 90% of cases, including in people who had previously failed HCV treatment.
On top of that, the drugs were far less toxic and required shorter treatment times than previously thought possible.
The aim of the current HCV therapies is fivefold and includes:
One of the most notable features of all DAAs is their price. They are all costly.
Before starting HCV therapy, you will undergo blood tests—called genotyping—to determine which HCV genotype (or genotypes) you have in your blood. This will help determine which DAA is the best fit for you as an individual.
In addition to genotyping, other factors help inform the drug choice and duration of therapy, including:
Once the DAA is prescribed, it is taken once daily for eight to 24 weeks. In certain cases, ribavirin may also be prescribed.
If the hepatitis C virus RNA remains undetectable for 12 weeks after the completion of therapy, it is referred to as a sustained virologic response (SVR). The treatment can be considered successful,and the infection can be considered cured.
Challenges and Limitations
Despite the exceptionally high cure rates, not everyone on HCV therapy will achieve SVR-12. If this happens to you, it may be because you’re not taking your drugs as prescribed, or it may be because you have an HCV genotype that is difficult to treat (such as HCV genotype 3 which is seen more commonly in Asia).
During the eight- to 24-week course of treatment, your healthcare provider will check your viral load at certain intervals to assess whether the drugs are working as they should.
By week four, a 99% drop in viral load—referred to as an early virologic response (EVR)—is usually a strong indication that you will achieve SVR-12.By week 12, the inability to achieve a two-log drop in viral load (for example, a drop from 1,000,000 to 10,000) is generally regarded as treatment failure.
Hepatitis C Treatment Costs: What to Expect
Getting Help With Hepatitis C Costs
The biggest challenge for some is not achieving SVR-12 but affording the cost of HCV therapy. Even if you are able to cover the out-of-pocket expenses, your health insurer might very well deny your request for treatment.
This doesn’t mean you should give up or wait until your condition gets worse before trying again. There are different steps you can take to not only access treatment but make the drugs more affordable.
Health Insurance
DenialsAccording to a 2020 study published inPublic Health Reports, Medicaid programs in Alabama, Arkansas, Indiana, Iowa, Louisiana, Maryland, Michigan, Montana, Nebraska, Oregon, South Dakota, Texas, and West Virginia still restrict access to DAAs based on the severity of liver disease, while 19 states restrict access based on sobriety programs ranging from one to six months.
Denials
According to a 2020 study published inPublic Health Reports, Medicaid programs in Alabama, Arkansas, Indiana, Iowa, Louisiana, Maryland, Michigan, Montana, Nebraska, Oregon, South Dakota, Texas, and West Virginia still restrict access to DAAs based on the severity of liver disease, while 19 states restrict access based on sobriety programs ranging from one to six months.
If you are among those who have been denied treatment, you have the right under federal law to appeal the judgment. There are different requirements and deadlines for filing an appeal, so it often helps to work with a liver specialist, such as agastroenterologistorhepatologist, who is experienced in providing a rationale for treatment.
If you cannot afford a liver specialist, you can often find low-cost or no-cost providers through the federal government’s Health Resources Services Administration (HRSA)online health center locator.
Patient Assistance Programs
Eligibility is typically based on whether your family’s annual income falls at or below 400%–500% of thefederal poverty level (FPL). Other manufacturer-subsidized programs are easier to access, providing assistance to not only low-income families but middle-income earners as well.
If you meet the eligibility requirements, the programs may help you cover:
Nonprofit Financial Assistance
In addition to manufacturer’s assistance programs, there are non-profit programs that provide financial assistance for hepatitis C treatment. You often have to check when funds are available, but, when they are, some organizations like the HealthWell Foundation offer grants of up to $30,000 per year for hepatitis C treatment.
Among the non-profits offering hepatitis C financial assistance are:
As with manufacturer’s assistance programs, nonprofit assistance programs are based on you or your family’s annual income. Generally, incomes that fall at or below 500% of the FPL qualify.
Drug Discount Cards
There are some specialty pharmacies and nonprofit organizations that offer drug discounts to reduce the cost of hepatitis C medications. Discounts can vary, but it is not uncommon to reap savings of 30% or more.
Discount Card BenefitsThe benefit of drug discount cards is that there are no eligibility requirements. You simply print out the discount card or download it onto your smartphone.
Discount Card Benefits
The benefit of drug discount cards is that there are no eligibility requirements. You simply print out the discount card or download it onto your smartphone.
Among the discount programs that can assist with hepatitis C treatment costs are:
Clinical Trials
Clinical trials, which are research studies to evaluate a medication or therapy before it is offered to the public, are another possible avenue for treatment, offering you benefits you might otherwise be unable to afford. If accepted into a study, you are typically provided medications, blood work, and clinical monitoring free or change. Some studies even pay their participants.
By participating in a clinical trial, you may benefit from the latest advances in medical science. In some cases, you may have access to new and improved treatments before the general public or be able to access treatment sooner than if you had to wait for insurance authorization.
Clinical trials may also be a good option if you have repeatedly failed HCV therapy and have yet to achieve SVR-12.
Ask your liver specialist about clinical trials you may be qualified for, or check theClinicalTrials.govwebsite for hepatitis C studies actively recruiting volunteers.
Coping and Living Well With Hepatitis C
Summary
The treatment of hepatitis C was transformed in 2013 with the introduction of a new class of drugs called direct-acting antivirals (DAAs), which today afford cure rates of over 90%. Even so, the drugs are expensive, and some health insurers have been known to deny coverage, particularly certain state Medicaid programs that restrict access based on disease severity or sobriety.
If faced with an insurance claim denial, you have the right to appeal the decision, ideally with the help of a gastroenterologist or hepatologist. You may also be eligible for patient assistance programs from drug manufacturers and nonprofit organizations like the PAN Foundation, which may cover some or all of the cost of treatment.
If you are ineligible for financial assistance due to your income, drug discount cards from specialist pharmacies and non-profit programs like NeedyMeds can help defray out-of-pocket expenses. You can also opt to participate in clinical trials, which may provide you access to hepatitis C therapies not yet available to the public or to medical care that might otherwise be unaffordable.
A Word From Verywell
Hepatitis C is more common than many people imagine. In the United States alone, 2.4 million people are thought to be infected, a great many of whom have no symptoms at all.Many of these infections occurred before 1965 when measures were put into place to screen the U.S. blood supply for viral hepatitis.
Because of this, the Centers for Disease Control and Prevention (CDC) recommends one-off testing for hepatitis C for all people aged 18 years and over, as well as for pregnant people with each pregnancy.
By getting tested early, you can get treated early and avoid any long-term injury to your liver.
Can You Tell If You Have Hepatitis C?
The average price of the five direct-acting antivirals (DAAs) used to treat hepatitis C can vary. At the low end, Zepatier and the authorized generic version of Epclusa cost roughly $24,000 for 12 weeks of treatment.Additionally, the authorized generic version of Harvoni costs $24,500 for 8 weeks of treatment. At the high end, Vosevi can cost over $74,640 for 12 weeks based on a review of current pharmacy prices on GoodRx and Drugs.com.
Yes, According to the Centers for Disease Control and Prevention (CDC), as many as 50% of people infected with the hepatitis C virus (HCV) will spontaneously clear the infection with no lasting consequences. But, of every 100 people infected with HCV, 5%–25% will develop cirrhosis within 10–20 years.
Learn MoreRacial Disparities in Hepatitis C Treatment
20 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Department of Health and Human Services.Hepatitis C basic information.
American Association for the Study of Liver Diseases, Infectious Diseases Society of America.When and in whom to initiate HCV therapy.
Henry B.Drug pricing & challenges to hepatitis C treatment access.J Health Biomed Law. 2018;14:265–83.
Bukh J.The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.J Hepatol.2016;65(1):S2-S21. doi:10.1016/j.jhep.2016.07.035
Thomas E, Ghany MG, Liang TJ.The application and mechanism of action of ribavirin in therapy of hepatitis C.Antivir Chem Chemother.2012 Sep 25;23(1):1–12. doi:10.3851/IMP2125
Carver AB, Zuckerman AD, DeClercq J, Choi L, Chastain CA.Incidence and impact of persistent viremia on SVR rates in patients receiving direct-acting antiviral therapy.Open Forum Infect Dis.2020;7(12):ofaa569. doi:10.1093/ofid/ofaa569
Department of Veteran Affairs.Hepatitis C medications: An overview for patients.
AASLD-IDSA HCV Guidance Panel.Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.Clin Infect Dis.2018:67(10):1477-92. doi:10.1093/cid/ciy585
Yoshida EM, Sulkowski MS, Gane EJ, et al.Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus.Hepatology. 2015;61(1):41–5. doi:10.1002/hep.27366
Ampuero J, Romero-Gomez M, Reddy K R.Review article: HCV genotype 3 – the new treatment challenge.Aliment Pharmacol Ther. 2014;39(7):686-98. doi:10.1111/apt.12646
Hutchinson Ja, Weigand K, Adenugba A.Predicting early viral control under direct-acting antiviral therapy for chronic hepatitis C virus using pretreatment immunological markers.Front Immunol.2018;9:146. doi:10.3389/fimmu.2018.00146
Im GY, Dieterich DT.Direct-acting antiviral agents in patients with hepatitis cirrhosis.Gastroenterol Hepatol (N Y).2012;8(11):727–65.
Greenwald R, Waters P, Cayer S.Enforcement of legal remedies to secure hepatitis C virus treatment with direct-acting antiviral therapies in correctional facilities and Medicaid programs.Public Health Rep.2020;135(1 Suppl):44S–49S. doi:10.1177/0033354920904608
Kaiser Family Foundation.Claims denials and appeals in ACA marketplace plans.
Department of Health and Human Services.Viral hepatitis in the United States: Data and trends.
Rein D, Smith BD, Wittenborn JS, Lesesne SB.The cost-effectiveness of birth cohort hepatitis C antibody screening in U.S. primary care settings.Ann Intern Med.2012;156:263–70. doi:10.7326/0003-4819-156-4-201202210-00378
Schillie S, Wester C. Osborne M, Wesolowski L, Ryerson AB.CDC recommendations for hepatitis C screening among adults — United States, 2020.MMWR Recomm Rep;2020;69(No. RR-2):1–17. doi:10.15585/mmwr.rr6902a1
OptumRx.Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) – first-time generics.
Centers for Disease Control and Prevention.Clinical overview of hepatitis C.
Meet Our Medical Expert Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?OtherHelpfulReport an ErrorSubmit
What is your feedback?
Symptoms of Hepatitis C VirusIs Rash a Sign of Hepatitis C?What Does Hepatitis C Treatment Cost?How Hepatitis C Is Transmitted (and How It Isn’t)
Symptoms of Hepatitis C Virus
Is Rash a Sign of Hepatitis C?
What Does Hepatitis C Treatment Cost?
How Hepatitis C Is Transmitted (and How It Isn’t)
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.Cookies SettingsAccept All Cookies
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies SettingsAccept All Cookies
